Education
About Us
Working with TipRanks
Follow Us
Xortx Therapeutics (XRTX)
:XRTX
Total Valuation
XORTX Therapeutics Inc has a market cap or net worth of $3.92M. The enterprise value is ―.
Market Cap$3.92M
Enterprise Value―
Share Statistics
XORTX Therapeutics Inc has 3,788,246 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,788,246
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
XORTX Therapeutics Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.08M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XORTX Therapeutics Inc is -1.52. XORTX Therapeutics Inc’s PEG ratio is -0.03.
PE Ratio-1.52
PS Ratio0.00
PB Ratio1.05
Price to Fair Value0.93
Price to FCF-0.84
Price to Operating Cash Flow-0.55
PEG Ratio-0.03
Income Statement
In the last 12 months, XORTX Therapeutics Inc had revenue of 0.00 and earned ― in profits. Earnings per share was -1.44.
Revenue0.00
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)-1.44
Cash Flow
In the last 12 months, operating cash flow was -4.09M and capital expenditures -44.68K, giving a free cash flow of -4.13M billion.
Operating Cash Flow-4.09M
Free Cash Flow-4.13M
Free Cash Flow per Share-1.09
Dividends & Yields
XORTX Therapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change-61.45%
50-Day Moving Average0.97
200-Day Moving Average1.25
Relative Strength Index (RSI)50.98
Average Volume (3m)57.57K
Important Dates
XORTX Therapeutics Inc upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 16, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
XORTX Therapeutics Inc as a current ratio of 13.80, with Debt / Equity ratio of 2.88%
Current Ratio13.80
Quick Ratio13.80
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio0.00
Taxes
In the past 12 months, XORTX Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
XORTX Therapeutics Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
XORTX Therapeutics Inc has $2.30M in cash and marketable securities with $61.47K in debt, giving a net cash position of -$2.24M billion.
Cash & Marketable Securities$2.30M
Total Debt$61.47K
Net Cash-$2.24M
Net Cash Per Share-$0.59
Tangible Book Value Per Share$2.25
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XORTX Therapeutics Inc is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside1421.78% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―